Introduction

This page provides a comprehensive analysis of the known insider trading history of Bruce D Given. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Bruce D Given has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ARWR / Arrowhead Pharmaceuticals, Inc. Chief Operating Officer 329,347
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Bruce D Given. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Bruce D Given as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -213 329,347 -0.06
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -830 329,560 -0.25
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -1,200 330,390 -0.36
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -1,454 331,590 -0.44
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -500 333,044 -0.15
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -700 850,730 -0.08 40.00 -28,000 34,029,200
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -204 851,430 -0.02 40.00 -8,160 34,057,200
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -213 851,634 -0.03 40.00 -8,520 34,065,360
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -830 851,847 -0.10 40.00 -33,200 34,073,880
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -1,200 852,677 -0.14 40.00 -48,000 34,107,080
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -1,454 853,877 -0.17 40.00 -58,160 34,155,080
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -500 855,331 -0.06 40.00 -20,000 34,213,240
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 213 855,831 0.02 5.20 1,108 4,450,321
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 830 855,618 0.10 5.19 4,308 4,440,657
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1,200 854,788 0.14 4.75 5,700 4,060,243
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1,454 853,588 0.17 14.54 21,141 12,411,170
2020-04-29 2020-04-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 500 852,134 0.06 7.75 3,875 6,604,038
2020-04-29 2020-04-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -200 333,544 -0.06
2020-04-29 2020-04-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -100 851,634 -0.01 40.00 -4,000 34,065,360
2020-04-29 2020-04-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale -200 851,734 -0.02 40.00 -8,000 34,069,360
2020-04-29 2020-04-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 200 851,934 0.02 5.19 1,038 4,421,537
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -5,300 333,744 -1.56
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -3,456 339,044 -1.01
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -3,700 342,500 -1.07
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -3,800 346,200 -1.09
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,805 851,734 -0.44 40.00 -152,200 34,069,360
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,454 855,539 -0.40 40.00 -138,160 34,221,560
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -5,300 858,993 -0.61 40.00 -212,000 34,359,720
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,456 864,293 -0.40 40.00 -138,240 34,571,720
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,700 867,749 -0.42 40.00 -148,000 34,709,960
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -3,800 871,449 -0.43 40.00 -152,000 34,857,960
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5,300 875,249 0.61 14.54 77,062 12,726,120
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 3,456 869,949 0.40 5.20 17,971 4,523,735
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 3,700 866,493 0.43 5.19 19,203 4,497,099
2020-04-22 2020-04-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 3,800 862,793 0.44 4.75 18,050 4,098,267
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -1,300 858,993 -0.15 60.99 -79,287 52,389,983
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -22,466 860,293 -2.54 60.37 -1,356,272 51,935,888
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -11,847 882,759 -1.32 59.57 -705,726 52,585,954
2020-01-03 2020-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 250,000 894,606 38.78
2019-03-01 2019-03-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -42,500 350,000 -10.83
2019-03-01 2019-03-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -42,500 644,606 -6.19 19.99 -849,575 12,885,674
2019-03-01 2019-03-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 42,500 687,106 6.59 2.01 85,425 1,381,083
2019-02-27 2019-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -42,500 392,500 -9.77
2019-02-27 2019-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -42,500 644,606 -6.19 18.98 -806,650 12,234,622
2019-02-27 2019-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 42,500 687,106 6.59 2.01 85,425 1,381,083
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -42,500 435,000 -8.90
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -42,500 644,606 -6.19 17.98 -764,150 11,590,016
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 42,500 687,106 6.59 2.01 85,425 1,381,083
2019-02-20 2019-02-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -26,250 644,606 -3.91 17.67 -463,838 11,390,188
2019-02-12 2019-02-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -42,500 477,500 -8.17
2019-02-12 2019-02-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -42,500 670,856 -5.96 17.06 -725,050 11,444,803
2019-02-12 2019-02-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 42,500 713,356 6.34 2.01 85,425 1,433,846
2019-02-12 2019-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -11,667 520,000 -2.19
2019-02-12 2019-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -57,000 670,856 -7.83 16.48 -939,360 11,055,707
2019-02-12 2019-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -97,167 727,856 -11.78 15.66 -1,521,635 11,398,225
2019-02-12 2019-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 11,667 825,023 1.43 2.62 30,568 2,161,560
2019-02-12 2019-02-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -11,667 531,667 -2.15
2019-02-12 2019-02-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -46,167 813,356 -5.37 15.34 -708,202 12,476,881
2019-02-12 2019-02-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 11,667 859,523 1.38 2.62 30,568 2,251,950
2019-02-07 2019-02-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -22,500 847,856 -2.59 14.48 -325,800 12,276,955
2019-02-01 2019-02-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -28,500 870,356 -3.17 13.85 -394,725 12,054,431
2019-01-24 2019-01-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -17,500 898,856 -1.91 13.15 -230,125 11,819,956
2019-01-24 2019-01-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -152,000 916,356 -14.23 13.59 -2,065,680 12,453,278
2019-01-16 2019-01-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -1,000 543,334 -0.18
2019-01-16 2019-01-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -11,666 544,334 -2.10
2019-01-16 2019-01-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -42,666 1,068,356 -3.84 14.40 -614,390 15,384,326
2019-01-16 2019-01-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1,000 1,111,022 0.09 6.20 6,200 6,888,336
2019-01-16 2019-01-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 11,666 1,110,022 1.06 2.62 30,565 2,908,258
2019-01-03 2019-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -20,000 1,098,356 -1.79 11.98 -239,600 13,158,305
2019-01-03 2019-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 210,000 1,118,356 23.12
2018-03-05 2018-03-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -20,000 908,356 -2.15 6.73 -134,600 6,113,236
2018-01-03 2018-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		S - Sale X -20,000 928,356 -2.11 3.69 -73,800 3,425,634
2018-01-03 2018-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 175,000 948,356 22.63
2017-01-04 2017-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock 		A - Award 380,000 773,356 96.60
2016-03-08 2016-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		F - Taxes -13,675 393,356 -3.36 4.33 -59,213 1,703,231
2016-02-09 2016-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		F - Taxes -17,969 407,031 -4.23 3.46 -62,173 1,408,327
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options 		A - Award 60,000 556,000 12.10
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 150,000 425,000 54.55
2015-03-06 2015-03-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options 		A - Award 60,000 496,000 13.76
2015-03-06 2015-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 150,000 275,000 120.00
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options 		A - Award 50,000 436,000 12.95
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock 		A - Award 125,000 125,000
2013-09-24 2013-09-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 40,000 386,000 11.56
2013-05-08 2013-05-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award 170,000 346,000 96.59
2012-10-02 2012-09-28 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option 		A - Award -35,000 176,000 -16.59
2012-07-09 2012-02-16 4/A ARWR ARROWHEAD RESEARCH CORP
Stock Option dated 02/16/12 		A - Award 110,000 141,000 354.84
2012-02-21 2012-02-16 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option dated 02/16/12 		A - Award -110,000 141,000 -43.82
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)